Breast Cancer (Metastases)

FDA Panel Backs Pill to Slow Spread of Advanced Disease

Published in Women's Health Weekly, March 30th, 1998

Women suffering advanced breast cancer that has spread to other organs may soon be able to take a pill in their quest to slow their incurable disease.

Advisors to the U.S. Food and Drug Administration (FDA) recommended on March 19, 1998, that the government approve the drug Xeloda, though they emphasized that the pill's usefulness is still largely unknown. Early suggestions that it could help shrink tumors by half among some women who have failed other therapies prompted the panel to back sale of the drug while its true effectiveness is still being studied.

"This is a fairly decent response rate," said Dr. Sandra Swain of the Comprehensive Breast...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1998-03-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry